Navigation Links
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Date:2/11/2013

SAN DIEGO, Feb. 11, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the fourth quarter of fiscal 2012 on Thursday, February 21.

The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time (5 p.m., Eastern Standard Time), Thursday, February 21, hosted by Scot Huennekens , president and chief executive officer, and John Dahldorf , chief financial officer.

The teleconference can be accessed by calling (631) 291-4555, passcode 90659548. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available through the company's website at www.volcanocorp.com.

A replay of the conference call will be available through Thursday, February 28, at (404) 537-3406, passcode 90659548, and via the company's website.

About Volcano Corporation
Volcano Corporation (Nasdaq: VOLC) is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. Fo
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
2. Volcano Corporation To Offer $350 Million Convertible Senior Notes Due 2017
3. Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
4. Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast
5. Fish & Richardson Prevails in Patent Infringement Trial for Volcano Corporation
6. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
7. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
8. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
9. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
10. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
11. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ... immune therapies for cancer, announced today that Dr. ... Company, will be making a presentation at the New ... Immunotherapy at 11:40 a.m. on May 21, 2015, at the ... Dr. Bosch,s presentation is entitled "DCVax-Direct, ...
(Date:5/21/2015)... and SEATTLE , May 21, ... the development of robotics, sensors and medical devices, announced ... the company,s Chief Financial Officer and head of Corporate ... in corporate development, business development and finance roles, including ... and Pendrell Corporation.  Mr. Woo will be located in ...
(Date:5/21/2015)... N.Y. , May 21, 2015 Hope ... groundbreaking national alliance with USA ... cards. The new nationwide initiative benefiting Hope For Heroes ... nation,s disabled military veterans, police, firemen, and EMS professionals, ... "Hope For Heroes is thrilled to welcome ...
Breaking Medicine Technology:NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy 2NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy 3Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2Hope For Heroes Joins Forces with USA Medical Card 2
... GREEN BAY, Wis., Sept. 16 Top researchers at ... Center in Dallas are exploring the clinical applications of ... potency, and bioavailability. Previous studies have ... than other forms of curcumin, and had a retention ...
... Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic... -- REGENSBURG, Germany, September ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; ...
Cached Medicine Technology:BCM-95 Demonstrates Superior Anti-Inflammatory Effects 2Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 2Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 3Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 4Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 5Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 6Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 7Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System 8
(Date:5/22/2015)... A new program for the "In America" television series ... Therapy. , James Earl Jones will host the ... therapy and discusses how the exercises can decrease pain ... ailments and injuries. Physical therapists work with their ... daily activities such as house cleaning and shopping, work ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Javon ... to be recognized for providing the highest quality emergency ... of health care decision-making,” said Javon R. Bea, President ... the commitment of our employee/partners to care for and ... , Hospitals do not apply for this award, but ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 WellCare Health Plans, ... has been selected by the Florida Healthy Kids Corporation (FHKC) ... years of age, as part of the Florida Healthy Kids ... Oct. 1, 2015, and may be extended for two additional ... to serve children in the FHK program who live in ...
(Date:5/21/2015)... How do you stop head lice epidemics in ... school administrators, but a Miami Lice Removal Company, Lice Troopers, ... Florida, is devising new ways to stop the spread. ... the first step is education and prevention. Despite the ubiquity ... how they spread are still widely misunderstood. Many continue to ...
(Date:5/21/2015)... May 21, 2015 Many probiotics taken ... on those with celiac disease according to a ... of the probiotics tested in the study contained gluten, ... dietary supplements and cause gastrointestinal inflammation for those suffering ... to gain consumer trust in gluten-free claims have turned ...
Breaking Medicine News(10 mins):Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4
... on April 24, approving by unanimous consent an amended version ... by a vote of 420-3. The House is expected to ... President Bush to sign the measure into law. , "After ... their genetic information cannot be used by health insurers or ...
... MyFluVaccine Portal a Next-generation Server Load ... Balancer Platform for Web Application Delivery, SAN JOSE, ... Enterprises, the nation,s largest distributor of plasma,products, vaccines and ... Manager to provide a Web application,delivery platform for its ...
... research with implications for people suffering from seasonal affective ... light to reset the biological clock through a mechanism ... suggest that patients with trouble sleeping or seasonal depression ... exposure to daylight -- could benefit from development of ...
... Christina Predicts, uncanny gift for communicating with infants helps ... parents understand their little ones better, FLANDERS, ... uncertainty, many people would welcome the opportunity to learn,what the ... psychic reader,Christina Predicts., The recent highlighting of self-awareness by ...
... IFLG ), a leading technology provider of ... will release its,financial results for the First Quarter ... Following the press release, President and Chief,Executive Officer ... will,host a conference call with the financial community ...
... JOLLA, Calif., April 25 Duska,Therapeutics, Inc. (OTC ... company developing medical products based on adenosine,5,-triphosphate (ATP) ... management and clinical and regulatory consultants met,on April ... and Drug Administration,(FDA) Division of Cardiovascular and Renal ...
Cached Medicine News:Health News:Genetic Information Nondiscrimination Act clears Senate 2Health News:FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager 2Health News:FFF Enterprises Selects A10 Networks' AX Series Advanced Traffic Manager 3Health News:Different processes govern sight, light detection 2Health News:Internationally Known Psychic Christina Predicts Guides Others to Embrace a More Spiritual Way of Life 2Health News:InfoLogix to Report First Quarter Results on April 30, 2008 2Health News:Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM) 2Health News:Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM) 3